Kidney Today Blog

Researchers Dr. David Collister and Dr. Emily Christie provide an overview of their research on gender identity and kidney health

A recap of the Emerging Innovations sessions of AKF's 2024 Kidney Action Week

Results from a recent clinical trial show promise for semaglutide as a treatment to help slow progression of kidney disease and reduce the risk of death from ki...

5 key takeaways from a national survey by KFF that sheds light on the experiences shared by many people of color when it comes to their health care needs

2023 was a big year for the kidney disease research and it can be challenging to keep up with it all. Fortunately, AKF has been keeping tabs on these headlines ...

The American Heart Association (AHA) defines and officially declares cardiovascular-kidney-metabolic (CKM) syndrome as a specific health condition, acknowledgin...

Last month, the American Heart Association shared the results of a study that found that Hispanic/Latino adults who have kidney disease may be at increased risk...

AKF is proud to launch the next step of the UCKD Project: the UCKD Coalition, which is comprised of 15 organizations and individuals who will work together to s...

AKF Clinical Scientist in Nephrology Fellow Christine P. Limonte describes some of the advances in understanding and treating diabetic kidney disease in the las...